Literature DB >> 233680

Effect of indomethacin on the hypothalamic-pituitary-adrenal axis in man.

J Beirne, W Jubiz.   

Abstract

The effect of the cyclo-oxygenase inhibitor, indomethacin, on hypothalamic-pituitary-adrenal function was investigated in five normal males. Baseline 0800 and 1600 h plasma ACTH and cortisol, plasma ACTH and 11-deoxycortisol responses to metyrapone, and plasma cortisol responses to dexamethasone and exogenous ACTH were not affected by indomethacin. However, the area under the curve for plasma ACTH after iv injection of regular insulin (0.1 U/kg) was significantly decreased during indomethacin administration (control, 88.0 +/- 32.6 cm2, mean +/- sd; indomethacin, 47.6 +/- 23.1, P less than 0.01). Plasma cortisol levels were decreased only at 30 min. Our results support the hypothesis that prostaglandins or any of their precursors play a role in the hypothalamic control of ACTH secretion and indicate that evaluation of hypophyseal ACTH secretory capacity by means of insulin-induced hypoglycemia may yield abnormal results in patients receiving indomethacin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 233680     DOI: 10.1210/jcem-47-4-713

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

1.  Effect of naproxen on the hypothalamic-pituitary-adrenal axis in healthy volunteers.

Authors:  Agnes M M Eijsbouts; Marlies J E Kempers; Renske S A Kramer; Maria T E Hopman; Frank H J van den Hoogen; Ronald F J M Laan; Ad R M M Hermus; Fred C G J Sweep; Leo B A van de Putte
Journal:  Br J Clin Pharmacol       Date:  2009-01       Impact factor: 4.335

2.  Feedback inhibition of adrenocorticotropic hormone by physiological increases in plasma corticosteroids in conscious dogs.

Authors:  M E Keller-Wood; J Shinsako; M F Dallman
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.